跳至主要内容
临床试验/NCT07006974
NCT07006974进行中(未招募)不适用

Patients With Left Ventricular Hypertrophy in Syndromic and Metabolic Cardiomyopathy Compared to Hypertrophic Cardiomyopathy: an Age-sex Matched Cohort Study

China National Center for Cardiovascular Diseases1 个研究点 分布在 1 个国家目标入组 165 人开始时间: 2025年5月27日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
165
试验地点
1
主要终点
primary outcome

研究概览

简要总结

The goal of this cohort study is to investigate the clinical characteristics of SMCs and to explore the difference in cardiovascular outcomes in comparison to age-, sex-, and admission year-matched HCM patients. The main question it aims to answer is:

  • Do patients with SMCs have higher rates of cardiac outcomes?
  • What risk factors do SMCs patients experience a poor prognosis?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •patients who were diagnosed SMCs or HCM. Gene testing and muscle biopsy were used to confirm the diagnosis of SMCs. The diagnose of HCM was according to the 2024 ESC Guidelines of HCM but without evidence of SMCs.
  • •complete baseline data
  • •accessible follow-up data

排除标准

  • •incomplete baseine data

结局指标

主要结局

primary outcome

时间窗: 3 years

a composite of all-cause death, hospitalization for heart failure, myocardial infarction, ischemia or hemorrhagic stroke (excluding transient ischemic attack), other thrombotic events, and modified International Society on Thrombosis and Haemostasis crit

次要结局

未报告次要终点

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验